Tasmania pilot to commence 1st March
February 22, 2024
Tasmanian pharmacists may be aware of the Tasmanian Community Pharmacy Program, scheduled to go live on 1 March 2024. Endorsed pharmacists practising in approved premises
Tasmanian pharmacists may be aware of the Tasmanian Community Pharmacy Program, scheduled to go live on 1 March 2024. Endorsed pharmacists practising in approved premises
Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program (OTP) in 2023, overcoming numerous challenges whilst maintaining uninterrupted service to
Pharmaceutical Defence Limited (PDL) is a member-owned organisation supporting around 31,000 pharmacist members and the pharmacy profession. The leading risk advisors to the profession, PDL’s
Notice is hereby given that the 111th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3,
Pharmaceutical Defence Limited (PDL) is a member owned organisation supporting around 31,000 pharmacist members and the pharmacy profession. The leading risk advisors to the profession,
Notice is hereby given that the 110th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3,
The following vacancies will occur as of the date of the next Annual General Meeting to be held on 20 October 2022 One Director
Following the retirement of Curtis Ruhnau, PDL is pleased to announce the appointment of Amanda Galbraith as the new Director for NSW and the ACT.
Due to the impending retirement of Curtis Ruhnau, expressions of interest are invited by PDL for the position of Director for New South Wales (with
Pharmaceutical Defence Limited (PDL) is a member owned organisation supporting around 30,000 pharmacist members and the pharmacy profession. The leading risk advisors to the profession,